Engineers Gate Manager’s Aldeyra Therapeutics ALDX Stock Holding History

Engineers Gate Manager’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-57,146	Closed	-$201K	–	1881
2023 Q4	$201K	Buy	+57,146	New	+$176K	0.01%	1642
2023 Q3	–	Sell	-13,200	Closed	-$111K	–	1762
2023 Q2	$111K	Sell	13,200 -825	-6%	-$8.13K	﹤0.01%	1558
2023 Q1	$139K	Buy	+14,025	New	+$99.1K	0.01%	1477
2022 Q1	–	Sell	-73,594	Closed	-$294K	–	1811
2021 Q4	$294K	Buy	+73,594	New	+$561K	0.01%	1420
2020 Q1	–	Sell	-13,900	Closed	-$81K	–	1536
2019 Q4	$81K	Buy	+13,900	New	+$80.3K	﹤0.01%	1550

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Engineers Gate Manager's ALDX Position: Q1 2024 in Review

Engineers Gate Manager sold out of Aldeyra Therapeutics (ALDX) in Q1 2024, closing a stake of 57,146 shares — an estimated $201K sold.

Engineers Gate Manager first reported a position in ALDX in Q4 2019 and held it in 5 quarters. The position peaked at $294K in Q4 2021. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.

Engineers Gate Manager reported no remaining Aldeyra Therapeutics position as of Q1 2024 after selling out during the quarter.
Engineers Gate Manager sold 57,146 Aldeyra Therapeutics shares in Q1 2024, an estimated $201K.
Engineers Gate Manager first reported a position in Aldeyra Therapeutics in Q4 2019 and held it in 5 quarters.
Engineers Gate Manager's Aldeyra Therapeutics position peaked at $294K in Q4 2021.
102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.